Evidence map›Paper›PMID 9744879›Full record

ArticleThe Journal of cell biology1998

A morphogenesis checkpoint monitors the actin cytoskeleton in yeast.

J N McMillan, R A Sia, D J Lew

Abstract read
In one paragraph

Article in The Journal of cell biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed.

  1. Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Expression of EndonucleaseCurrent issues in molecular biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Septin-Associated Protein Kinases in the YeastFrontiers in cell and developmental biology · 2016
    Review
  17. Article
  18. Morphogenesis checkpoint kinase Swe1 is the executor of lipolysis-dependent cell-cycle progression.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  19. Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J N McMillanDepartment of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
R A Sia
D J Lew

Funding

CELL CYCLE CHECKPOINT THAT MONITORS MORPHOGENESISR01GM053050 · NIGMS · DUKE UNIVERSITY · PI LEW, DANIEL J · 1995 to 2012
$4.0M
MORPHOGENESIS CELL CYCLE CHECKPOINT IN BUDDING YEASTF32GM018455 · NIGMS · DUKE UNIVERSITY · PI MC MILLAN, JOHN N · 1996 to 1997
–
NIGMS NIH HHS F32 GM018455NIGMS NIH HHS GM18455NIGMS NIH HHS GM53050NIGMS NIH HHS R01 GM053050
6 · The paper itself

Abstract

A morphogenesis checkpoint in budding yeast delays cell cycle progression in response to perturbations of cell polarity that prevent bud formation (Lew, D.J., and S.I. Reed. 1995. J. Cell Biol. 129:739- 749). The cell cycle delay depends upon the tyrosine kinase Swe1p, which phosphorylates and inhibits the cyclin-dependent kinase Cdc28p (Sia, R.A.L., H.A. Herald, and D.J. Lew. 1996. Mol. Biol. Cell. 7:1657- 1666). In this report, we have investigated the nature of the defect(s) that trigger this checkpoint. A Swe1p- dependent cell cycle delay was triggered by direct perturbations of the actin cytoskeleton, even when polarity establishment functions remained intact. Furthermore, actin perturbation could trigger the checkpoint even in cells that had already formed a bud, suggesting that the checkpoint directly monitors actin organization, rather than (or in addition to) polarity establishment or bud formation. In addition, we show that the checkpoint could detect actin perturbations through most of the cell cycle. However, the ability to respond to such perturbations by delaying cell cycle progression was restricted to a narrow window of the cell cycle, delimited by the periodic accumulation of the checkpoint effector, Swe1p.

Indexed as

Signal TransductionActinsBridged Bicyclo Compounds, HeterocyclicCell CycleCell Cycle ProteinsCell NucleusCytoskeletonMorphogenesisProtein-Tyrosine KinasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsThiazolesThiazolidinesActinsBridged Bicyclo Compounds, HeterocyclicCell Cycle Proteinslatrunculin AProtein-Tyrosine KinasesSaccharomyces cerevisiae ProteinsSWE1 protein, S cerevisiaeThiazolesThiazolidines

Identifiers

PMID9744879
PMCPMC2141759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.